iSpecimen Expands Support of COVID-19 Research with Availability of Sequenced Specimens to Detect Variants By isp_developer | January 13, 2022 Read More
iSpecimen to Participate in the H.C. Wainwright BioConnect Conference on January 10-13, 2022 By isp_developer | January 4, 2022 Read More
iSpecimen Expands Global Biospecimen Supplier Network, Broadening Footprint Around the World By isp_developer | December 16, 2021 Read More
iSpecimen Expands Supplier Network of Human Biospecimens to Help Advance Research in Neurological Disorders By isp_developer | December 2, 2021 Read More
iSpecimen Inc. Announces Closing of Approximately $21 Million Private Placement By isp_developer | December 1, 2021 Read More
iSpecimen Inc. Announces $21 Million Private Placement By isp_developer | November 29, 2021 Read More
iSpecimen Selected by U.S. Government and Private Researchers to Supply Critical Human Biospecimens for Advanced Phase of COVID-19 Research By isp_developer | November 22, 2021 Read More
iSpecimen to Participate in Upcoming Conferences in November 2021 By isp_developer | November 1, 2021 Read More
iSpecimen Appoints Erik Uribe as Director of Global Implementations By isp_developer | October 26, 2021 Read More
